Comment on the article: “Main clinical factors associated with hypoglycemia in patients with type 2 diabetes”
Main Article Content
Keywords
Diabetes Mellitus, Type 2, Hypoglycemia, Insulin, Glyburide
Abstract
We read with interest the publication titled “Principales factores clínicos asociados a hipoglucemia en pacientes con diabetes tipo 2”, which highlights the relevance of time since diagnosis, age, and educational level as non-modifiable risk factors for hypoglycemia detected in the emergency department. In this context, we propose an argument suggesting the need for a subanalysis of pharmacological treatment by specific drug type, which could reveal a modifiable risk factor for the prevention of hypoglycemia in patients with type 2 diabetes mellitus.
References
2. Qaseem A, Obley AJ, Shamiliyan T, et al. New Pharmacologic treatments in adults with type 2 diabetes: a clinical guidelines from the American College of Physicians. Ann Intern Med. 2024;177(5):658-66.
3. American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes-2025. Diabetes Care. 2025;48(Supplement 1):S181-206. Disponible en: http://dx.doi.org/10.2337/dc25-S009.
4. Instituto Mexicano del Seguro Social. Diagnóstico y tratamiento farmacológico de la diabetes mellitus tipo 2 en el primer nivel de atención. Guía de Evidencias y Recomendaciones: Guía de práctica clínica. México: IMSS; 2018. Disponible en: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/718GER.pdf
5. Tsapas A, Avgerinos I, Karagiannis T, et al. Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: A systematic review and network meta-analysis. Ann Intern Med. 2020;173(4):278-86. Disponible en: http://dx.doi.org/10.7326/M20-0864
6. Instituto Mexicano del Seguro Social. Adquisiciones del IMSS. México: IMSS; [fecha de publicación o actualización desconocida] [consultado 2025 Mar 30]. Disponible en: http://compras.imss.gob.mx/?P=imsscomprofich&f=22418156
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.